SEC Company Response from MEDICINOVA INC (MNOV) (CIK 0001226616) (MNOV) — Aug 25, 2016
MEDICINOVA INC (MNOV) (CIK 0001226616)
Date: Aug. 25, 2016 · CIK: 0001226616 · Accession: 0001193125-16-691840
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-208274
Letter
August 25, 2016
VIA EDGAR
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Mail Stop 4720
Washington, D.C. 20549
Attention:
Ms. Suzanne Hayes, Assistant Director
Mr. Scot Foley, Attorney-Adviser
Re: Acceleration Request of Medicinova, Inc.
Registration Statement on Form S-3, filed December 1, 2015,
as amended on December 18, 2015 and August 24, 2016
(File No. 333-208274)
Ladies and Gentlemen:
Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, Medicinova, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effectiveness of the above-referenced Registration Statement, to 4:00 p.m., Eastern Time, on Monday, August 29, 2016, or as soon thereafter as practicable.
The Registrant hereby acknowledges that:
•
should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
•
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
•
the Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Thank you for your assistance. If you should have any questions, please contact Ryan Gunderson of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, at (858) 436-8046.
Very truly yours,
/s/ Yuichi Iwaki
Show Raw Text
CORRESP 1 filename1.htm CORRESP August 25, 2016 VIA EDGAR Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Mail Stop 4720 Washington, D.C. 20549 Attention: Ms. Suzanne Hayes, Assistant Director Mr. Scot Foley, Attorney-Adviser Re: Acceleration Request of Medicinova, Inc. Registration Statement on Form S-3, filed December 1, 2015, as amended on December 18, 2015 and August 24, 2016 (File No. 333-208274) Ladies and Gentlemen: Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, Medicinova, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effectiveness of the above-referenced Registration Statement, to 4:00 p.m., Eastern Time, on Monday, August 29, 2016, or as soon thereafter as practicable. The Registrant hereby acknowledges that: • should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; • the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and • the Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Thank you for your assistance. If you should have any questions, please contact Ryan Gunderson of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, at (858) 436-8046. Very truly yours, /s/ Yuichi Iwaki Yuichi Iwaki President and Chief Executive Officer